S. Karp

发表

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

M N Pollak, J C Zhang, L. Bégin, 1997, Cancer.

Evaluation of stereotactic core needle biopsy (SCNB) of the breast at a single institution

H. Bear, E. D. Paredes, S. Karp, 2000, Breast Cancer Research and Treatment.

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability

S. Rosenberg, J. Mulé, N. Restifo, 1992, The Journal of experimental medicine.

Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.

S. Steinberg, W. Linehan, S. Rosenberg, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hexokinase type II: a novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells.

G. Batist, S. Karp, M. Katabi, 1999, Human gene therapy.

Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer

H. Bear, L. Penberthy, S. Karp, 2003, Journal of surgical oncology.

Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence–Guided System

Barbara L. Smith, K. Hunt, A. Chagpar, 2022, JAMA surgery.

Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factor.

A. Asher, S. Rosenberg, P. Hwu, 1993, Journal of immunology.

Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for interleukin-2.

W. Linehan, P. Hwu, J. Mulé, 1992, Human gene therapy.

In vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumor.

S. Rosenberg, P. Hwu, J. Mulé, 1992, Journal of immunology.

A murine model for the immunotherapy of head and neck squamous cell carcinoma

G. Shenouda, M. Hier, S. Karp, 1995, The Laryngoscope.

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.

M. Brackstone, L. Gaboury, A. Robidoux, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical management of BRCA1- and BRCA2-associated breast cancer.

S. Karp, 2000, Seminars in surgical oncology.

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.

L. Bégin, W. Foulkes, P. Tonin, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Retroviral transduction of interferon-γ cDNA into a nonimmunogenic murinefibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor

S. Rosenberg, J. Mulé, N. Restifo, 1993, Cancer Immunology, Immunotherapy.

The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

C B Begg, W Foulkes, K Offit, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Generation of therapeutic T cells from draining lymph nodes in a murine model of head and neck squamous cell carcinoma.

G. Shenouda, M. Hier, S. Karp, 1997, Archives of otolaryngology--head & neck surgery.

Do breast cancer tumours downsize as well as downgrade with neoadjuvant chemotherapy?

J. Mcdonnell, S. Karp, M. Dani, 2007, Breast Cancer Research.

Germ-Line BRCA 1 Mutation Is an Adverse Prognostic Factor in Ashkenazi Jewish Women with Breast Cancer 1

L. Bégin, W. Foulkes, P. Tonin, 2005 .

Low-dose intravenous bolus interleukin-2 with interferon-alpha therapy for metastatic melanoma and renal cell carcinoma.

S. Karp, 1998, Journal of immunotherapy.

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.

M. Brackstone, L. Gaboury, A. Robidoux, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract CT166: Expansion into multiple institutions for training in the use of the LUM Imaging System for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer

Barbara L. Smith, K. Hunt, A. Chagpar, 2018, Clinical Trials.